4.6 Article

Impact of comprehensive family history and genetic analysis in the multidisciplinary pancreatic tumor clinic setting

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Long-term yield of pancreatic cancer surveillance in high-risk individuals

Kasper A. Overbeek et al.

Summary: The study aimed to determine the long-term yield of pancreatic cancer surveillance in hereditary high-risk individuals. Results showed substantial diagnostic yield in high-risk mutation carriers, but non-existent in mutation-negative familial pancreatic cancer (FPC) kindreds. Challenges in timely identification of resectable lesions were encountered despite concurrent use of EUS and MRI/MRCP, with the need for more sensitive diagnostic markers, including biomarkers, highlighted.
Article Genetics & Heredity

Oncology clinic-based germline genetic testing for exocrine pancreatic cancer enables timely return of results and unveils low uptake of cascade testing

Yifan Wang et al.

Summary: The study investigated the impact of an ambulatory oncology clinic-based genetic testing model on patients with pancreatic cancer. It found that a higher proportion of patients received prospective genetic testing and had a higher rate of pathogenic germline alterations using this model. Additionally, patients in this model had a shorter turnaround time for genetic testing reports.

JOURNAL OF MEDICAL GENETICS (2022)

Review Oncology

Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis

Jenny Lin et al.

Summary: This study evaluates the literature on genetic assessment for women with ovarian cancer and finds that rates of genetic testing remain below the goal of universal testing. Interventions such as mainstreaming can improve testing uptake, and strategies to improve utilization of genetic services should consider existing disparities in race and insurance status.

GYNECOLOGIC ONCOLOGY (2021)

Article Genetics & Heredity

Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer

Jada G. Hamilton et al.

Summary: The mainstreaming genetic testing model was well-received by most patients, with high satisfaction reported for testing decisions. However, variability in outcomes was observed based on result type, sex, and cancer type, indicating potential impact on depression and uncertainty levels.

GENETICS IN MEDICINE (2021)

Article Oncology

Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic Adenocarcinoma

Evan J. Walker et al.

Summary: By implementing a systematic patient intake workflow and establishing an in-clinic genetic testing station, the study successfully increased rates of genetic counseling and completion of germline testing for pancreatic cancer patients. The research identified that younger, non-Hispanic White, and English-speaking patients were more likely to complete testing.

ONCOLOGIST (2021)

Article Oncology

Implementing Systematic Genetic Counseling and Multigene Germline Testing for Individuals With Pancreatic Cancer

Anu Chittenden et al.

Summary: The study aimed to assess the real-world effectiveness of implementing systematic genetic counseling and multigene germline testing (GC/MGT) for all patients with pancreatic ductal adenocarcinoma (PDAC) at a high-volume academic institution. The implementation of automated referrals led to a significant increase in the uptake of GC/MGT among PDAC patients and improved time to testing. Results showed that systematic GC/MGT is feasible and leads to management changes for patients with PDAC and their families.

JCO ONCOLOGY PRACTICE (2021)

Article Gastroenterology & Hepatology

Surgical Outcomes After Pancreatic Resection of Screening-Detected Lesions in Individuals at High Risk for Developing Pancreatic Cancer

Marcia Irene Canto et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2020)

Review Oncology

Retrospective review of outcomes in patients with DNA-damage repair related pancreatic cancer

Sarah K. Macklin-Mantia et al.

HEREDITARY CANCER IN CLINICAL PRACTICE (2020)

Article Medicine, General & Internal

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer

Talia Golan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Medicine, General & Internal

Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement

Douglas K. Owens et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Article Oncology

Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion

Elena M. Stoffel et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

Article Oncology

Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program

Tanya Dwarte et al.

HEREDITARY CANCER IN CLINICAL PRACTICE (2019)

Article Oncology

Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients

Chunling Hu et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)

Article Surgery

A pancreatic cancer multidisciplinary clinic: insights and outcomes

Suzanne C. Schiffman et al.

JOURNAL OF SURGICAL RESEARCH (2016)

Review Gastroenterology & Hepatology

ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes

Sapna Syngal et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)

Article Gastroenterology & Hepatology

Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients With Pancreatic Cancer

Robert C. Grant et al.

GASTROENTEROLOGY (2015)

Article Medicine, General & Internal

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

D. T. Le et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)